Physicochemical Properties
| Molecular Formula | C28H36N2O2F2 |
| Molecular Weight | 470.59444 |
| Exact Mass | 470.274 |
| CAS # | 862281-92-3 |
| PubChem CID | 11328898 |
| Appearance | White to off-white solid powder |
| LogP | 4.656 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 34 |
| Complexity | 708 |
| Defined Atom Stereocenter Count | 4 |
| SMILES | C[C@@H]1CN(C[C@@H](C1(C2=CC=CC=C2)O)C)C(=O)[C@@H]3CN(C[C@H]3C4=C(C=C(C=C4)F)F)C(C)(C)C |
| InChi Key | WHPJOAUPIZDJNX-YTEQHECZSA-N |
| InChi Code | InChI=1S/C28H36F2N2O2/c1-18-14-31(15-19(2)28(18,34)20-9-7-6-8-10-20)26(33)24-17-32(27(3,4)5)16-23(24)22-12-11-21(29)13-25(22)30/h6-13,18-19,23-24,34H,14-17H2,1-5H3/t18-,19+,23-,24+,28?/m0/s1 |
| Chemical Name | [(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]-[(3S,5R)-4-hydroxy-3,5-dimethyl-4-phenylpiperidin-1-yl]methanone |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | MC4 absorption is bound by PF-00446687, which has a Ki of 27±4 nM. PF-00446687 exhibits very low efficacy against MC1, MC3, and MC5 uptake, as seen by its respective EC50 values of 1.02±0.30 μM, 1.16±0.35 μM, and 1.98±0.20 μM. The CEREP Bioprint Broad Ligand Screening Panel assessed PF-00446687's extensive off-target profile and found that the compound had the strongest binding activity at muscarinic M2 uptake (Ki=730 nM), sodium channels (Ki=690 nM), and sigma receptors (Ki=330 nM) [1]. |
| ln Vivo | Internally reaching the brain, Pf-446687 is stable and has great selectivity for MC4R. In prairie voles, but not in non-monogamous meadow voles, peripheral injection of the highly selective small molecule MC4R agonist Pf-446687 and the brain-penetrating MC3/4R receptor peptide agonist Melanotan II (MTII) can accelerate the establishment of dietary preferences. It is devoid of any [2]. |
| References |
[1]. Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humans. J Med Chem. 2010 Apr 22;53(8):3183-97. [2]. Melanocortin Receptor Agonists Facilitate Oxytocin-Dependent Partner Preference Formation in the Prairie Vole. Neuropsychopharmacology. 2015 Jul;40(8):1856-65. |
| Additional Infomation | PF-00446687 has been investigated for the treatment of Erectile Dysfunction. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~62.5 mg/mL (~132.81 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (4.42 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (4.42 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (4.42 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1250 mL | 10.6250 mL | 21.2499 mL | |
| 5 mM | 0.4250 mL | 2.1250 mL | 4.2500 mL | |
| 10 mM | 0.2125 mL | 1.0625 mL | 2.1250 mL |